Increased expression and co-localization of ACE, angiotensin II AT1 receptors and inducible nitric oxide synthase in atherosclerotic human coronary arteries

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 2, Issue 2, 2010, Pages 111-124

  Ohishi, Mitsuru ^a,b   Dusting, Gregory J ^b   Fennessy, Paul A ^b   Mendelsohn, Frederick A O ^b   Li, Xiao C ^c   Zhuo, Jia L ^b,c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Angiotensin converting enzyme; Angiotensin II; Atherosclerosis; Human coronary artery; Immunohistochemistry; Nitric oxide synthase

Indexed keywords

ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; RAS PROTEIN; REACTIVE OXYGEN METABOLITE;

ADULT; ANTHROPOMETRY; ARTICLE; ATHEROSCLEROSIS; AUTORADIOGRAPHY; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENDOTHELIUM CELL; ENZYME ACTIVITY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PATIENT INFORMATION; PATIENT SELECTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESEARCH SUBJECT; SMOOTH MUSCLE FIBER;

EID: 77954735297     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Daugherty A, Manning MW and Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105(11):1605-1612.
2. Berk BC, Haendeler J and Sottile J. Angiotensin II, atherosclerosis, and aortic aneurysms. J Clin Invest 2000; 105(11):1525-1526.
3. Weiss D, Kools JJ and Taylor WR. Angiotensin II induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 2001; 103(3):448-454.
4. van Kleef EM, Fingerle J and Daemen MJ. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated. Arterioscler Thromb Vasc Biol 1996; 16(7):857-863.
5. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342(3):145-153.
6. Holmgren A, Pantev E, Erlinge D and Edvinsson L. Inhibition of angiotensin II-induced contraction by losartan in human coronary arteries. J Cardiovasc Pharmacol 1998; 32(4):662-664.
7. Hafizi S, Chester AH, Allen SP, Morgan K and Yacoub MH. Growth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade. Coron Artery Dis 1998; 9(4):167-175.
8. Zhuo JL, Froomes P, Casley D, Liu JJ, Murone C, Chai SY, Buxton B and Mendelsohn FA. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease. Circulation 1997; 96 (1):174-182.
9. Zhuo JL, Casley D, Murone C and Mendelsohn FA. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit. J Cardiovasc Pharmacol 1997; 29(3):297-310.
10. Zhuo JL, Moeller I, Jenkins T, Chai SY, Allen AM, Ohishi M and Mendelsohn FA. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors. J Hypertens 1998; 16(12 Pt 2):2027-2037.
11. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ and Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 1994; 93(1):339-346.
12. Ohishi M, Ueda M, Rakugi H, Naruko T, Kojima A, Okamura A, Higaki J and Ogihara T. Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans. J Hypertens 1997; 15 (11):1295-1302.
13. Ohishi M, Ueda M, Rakugi H, Okamura A, Naruko T, Becker AE, Hiwada K, Kamitani A, Kamide K, Higaki J and Ogihara T. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation 1997; 96(10):3328-3337.
14. Haberbosch W, Bohle RM, Franke FE, Danilov S, Alhenc-Gelas F, Braun-Dullaeus R, Holschermann H, Waas W, Tillmanns H and Gardemann A. The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions. Atherosclerosis 1997; 130(1-2):203-213.
15. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH and Dzau VJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996; 94(11):2756-2767.
16. Wever RM, Luscher TF, Cosentino F and Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998; 97(1):108-112.
17. Ravalli S, Albala A, Ming M, Szabolcs M, Barbone A, Michler RE and Cannon PJ. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation 1998; 97 (23):2338-2345.
18. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci 1997; 811:60-67.
19. Groves PH, Banning AP, Penny WJ, Newby AC, Cheadle HA and Lewis MJ. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc Res 1995; 30(1):87-96.
20. Moncada S, Higgs A and Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev 1997; 49 (2):137-142.
21. Topper JN, Cai J, Falb D and Gimbrone MAJr. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A.1996; 93(19):10417-10422.
22. Oemar BS, Yang Z and Luscher TF. Molecular and cellular mechanisms of atherosclerosis. Curr Opin Nephrol Hypertens 1995; 4(1):82-91.
23. Depre C, Havaux X, Renkin J, Vanoverschelde JL and Wijns W. Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque. Cardiovasc Res 1999; 41(2):465-472.
24. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T and Luscher TF. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998; 97 (25):2494-2498.
25. Thorup C, Kornfeld M, Winaver JM, Goligorsky MS and Moore LC. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflugers Arch 1998; 435 (3):432-434.
26. Olson SC, Dowds TA, Pino PA, Barry MT and Burke-Wolin T. ANG II stimulates endothelial nitric oxide synthase expression in bovine pulmonary artery endothelium. Am J Physiol 1997; 273 (2 Pt 1):L315-L321.
27. Dubey RK, Jackson EK and Luscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclicnucleotides and angiotensin1 receptors. J Clin Invest 1995; 96(1):141-149.
28. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K and Takeshita A. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998; 31(1 Pt 2):342-348.
29. Pollman MJ, Yamada T, Horiuchi M and Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 1996; 79(4):748-756.
30. Okamura A, Rakugi H, Ohishi M, Yanagitani Y, Takiuchi S, Moriguchi K, Fennessy PA, Higaki J and Ogihara T. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertens 1999; 17(4):537-545.
31. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull WJr, Rosenfeld ME, Schwartz CJ, Wagner WD and Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92(5):1355-1374.
32. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr., Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD and Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994; 89(5):2462-2478.
33. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull WJr, Richardson M, Rosenfeld ME, Schaffer SA, Schwartz CJ and Wagner WD. A definition of the intima of human arteries and of its atherosclerosisprone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1992; 85(1):391-405.
34. Takada Y, Kitami Y, Inoue Y, Hiwada K and Kokubu T. Immunohistologic characterization of angiotensin converting enzyme in the human kidney using monoclonal and polyclonal antibodies. Adv Exp Med Biol 1989; 247A:175-180.
35. Rakugi H, Okamura A, Kamide K, Ohishi M, Sasamura H, Morishita R, Higaki J and Ogihara T. Recognition of tissueand subtype-specific modulation of angiotensin II receptors using antibodies against AT1 and AT2 receptors. Hypertens Res 1997; 20(1):51-55.
36. Zhuo JL, Ohishi M and Mendelsohn FA. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney. Hypertension 1999; 33(1 Pt 2):347-353.
37. Ohishi M, Ueda M, Tanabe S, Han YS, Mendelsohn FAO and Zhuo JL. Increased angiotensinconverting enzyme and type 1 angiotensin receptors in cortical vasculature and tubulointerstitium of chronically rejected human kidney allografts. Nephrology 2001; 6(5):223-232.
38. Song K, Shiota N, Takai S, Takashima H, Iwasaki H, Kim S and Miyazaki M. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of highcholesterol fed Cynomolgus monkeys. Atherosclerosis 1998; 138(1):171-182.
39. Yang BC, Phillips MI, Mohuczy D, Meng H, Shen L, Mehta P and Mehta JL. Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1998; 18(9):1433-1439.
40. Ohishi M, Ueda M, Rakugi H, Naruko T, Kojima A, Okamura A, Higaki J and Ogihara T. Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions. J Hypertens 1999; 17 (4):547-553.
41. Hoshida S, Kato J, Nishino M, Egami Y, Takeda T, Kawabata M, Tanouchi J, Yamada Y and Kamada T. Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome. Circulation 2001; 103(5):630-633.
42. Keidar S, Kaplan M, Hoffman A and Aviram M. Angiotensin II stimulates macrophage-mediated oxidation of low-density lipoproteins. Atherosclerosis 1995; 115(2):201-215.
43. Scheidegger KJ and Wood JM. Local application of angiotensin II to the rat carotid artery induces adventitial thickening. J Vasc Res 1997; 34 (6):436-446.
44. Kuhlencordt PJ, Gyurko R, Han F, ScherrerCrosbie M, Aretz TH, Hajjar R, Picard MH and Huang PL. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001; 104(4):448-454.
45. Arthur JF, Yin ZL, Young HM and Dusting GJ. Induction of nitric oxide synthase in the neointima induced by a periarterial collar in rabbits. Arterioscler Thromb Vasc Biol 1997; 17(4):737-740.
46. Gonzalez-Fernandez F, Lopez-Farre A, RodriguezFeo JA, Farre J, Guerra J, Fortes J, Millas I, Garcia-Duran M, Rico L, Mata P, de Miguel LS and Casado S. Expression of inducible nitric oxide synthase after endothelial denudation of the rat carotid artery: role of platelets. Circ Res 1998; 83(11):1080-1087.
47. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH and Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996; 75(1):77-85.
48. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG and Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 1997; 17 (11):2479-2488.
49. Orsi A, Beltran B, Clementi E, Hallen K, Feelisch M and Moncada S. Continuous exposure to high concentrations of nitric oxide leads to persistent inhibition of oxygen consumption by J774 cells as well as extraction of oxygen by the extracellular medium. Biochem J 2000; 346 Pt 2:407-412.